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Abstract
Elongation of the poly(A) tails of specific mRNAs in the cytoplasm is a crucial regulatory step in oogenesis and early development of many
animal species. The best studied example is the regulation of translation by cytoplasmic polyadenylation elements (CPEs) in the 3′ untranslated
region of mRNAs involved in Xenopus oocyte maturation. In this review we discuss the mechanism of translational control by the CPE binding
protein (CPEB) in Xenopus oocytes as follows:
1. The cytoplasmic polyadenylation machinery such as CPEB, the subunits of cleavage and polyadenylation specificity factor (CPSF), symplekin,
Gld-2 and poly(A) polymerase (PAP).
2. The signal transduction that leads to the activation of CPE-mediated polyadenylation during oocyte maturation, including the potential roles of
kinases such as MAPK, Aurora A, CamKII, cdk1/Ringo and cdk1/cyclin B.
3. The role of deadenylation and translational repression, including the potential involvement of PARN, CCR4/NOT, maskin, pumilio, Xp54 (Ddx6,
Rck), other P-body components and isoforms of the cap binding initiation factor eIF4E.
Finally we discuss some of the remaining questions regarding the mechanisms of translational regulation by cytoplasmic polyadenylation and
give our view on where our knowledge is likely to be expanded in the near future.
© 2008 Elsevier B.V. Open access under CC BY license.Keywords: Cytoplasmic polyadenylation; Oocyte; Meiotic maturation; Translational control; Deadenylation1. Introduction
The regulation of translation of mRNAs by cytoplasmic elon-
gation of the poly(A) tail was discovered some twenty years ago
in the oocytes and early embryos of clams, worms, frogs andmice
[1–6]. These maternal mRNAs are stored in the growing oocyte
with a short poly(A) tail of 20 to 40 nucleotides and are trans-
lationally repressed (masked). Upon oocyte maturation or after
fertilisation, the poly(A) tail of masked mRNAs is elongated to
80–250 residues and the mRNAs are translationally activated. A
long poly(A) tail is thought to be stimulatory to translation
through the binding of cytoplasmic poly(A) binding proteins,
which recruit initiation factors and form a closed-loop complex
through their association with the translation initiation factor⁎ Corresponding author. Fax: +44 0115 8468002.
E-mail address: cornelia.demoor@nottingham.ac.uk (C.H. de Moor).
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Open access under CC BY license.eIF-4G [7]. Cytoplasmic polyadenylation is essential for the
meiotic maturation of the oocyte in both Xenopus and mouse, as
it mediates the translational activation of the mRNAs encoding
c-Mos kinase and mitotic cyclins [8]. In addition, cytoplasmic
polyadenylation has been implicated in the cell cycle, in cellular
senescence and in the formation of memory through synaptic
plasticity [9]. In this review we will discuss the current know-
ledge of the mechanism of translational control by cytoplasmic
polyadenylation, with an emphasis on Xenopus oocyte matura-
tion and CPEB, the cytoplasmic polyadenylation element bind-
ing protein. A review of the role of cytoplasmic polyadenylation
in mammalian gametogenesis is provided elsewhere in this
volume (Tadashi Baba).
2. mRNA elements and RNA binding proteins
In order for mRNAs to be singled out for cytoplasmic poly-
adenylation, they have to be recognised by the polyadenylation
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frog, Xenopus, cytoplasmic polyadenylation can be conferred by
several discrete elements in the 3′ untranslated region (3′UTR) of
the mRNA which are recognised by specific RNA binding
proteins. At least 4 different cytoplasmic polyadenylation ele-
ments have been identified in Xenopus. The C-rich cytoplasmic
polyadenylation element and the U-rich embryonic cytoplasmic
polyadenylation element normally mediate cytoplasmic poly-
adenylation in the zygote and early embryo [10,11]. The putative
cytoplasmic polyadenylation factors binding to these elements are
poly(rC) binding protein 2 (PCBP2) and Elav related protein A,
the ortholog of HuR, respectively [10,12–14]. A polyadenylation
element that functions early in oocyte maturation, the poly-
adenylation response element (PRE), was predicted computa-
tionally [15,16]. The RNA binding proteinMusashi was shown to
bind to some, but not all PREs andmutatingMusashi or its known
consensus binding site blocked cytoplasmic polyadenylation,
indicating that it is likely to be a cytoplasmic polyadenylation
factor [17]. These data suggest that the collection of cytoplasmic
polyadenylation elements that have been called PREs may
represent a mixture ofMusashi binding sites and at least one more
uncharacterised cytoplasmic polyadenylation element.
By far the best characterised cytoplasmic polyadenylation
element is the CPE, which is required for the cytoplasmic poly-
adenylation of a number of mRNAs, including cyclin B1mRNA,
during oocyte maturation and during the embryonic cell cycle
[18–20]. The consensus CPE is often described as U5AU, but
variations such as U4AU (c-mos), and U4–5A2U (cyclin B1) have
also been shown to be active [5,6,21,22]. The CPEs in themRNA
encodingmouse c-Mos are active inmatureXenopus oocytes, but
only conform toU5A [23,24]. Strongly polyadenylatingmRNAs,
however, generally adhere to the U5A1–2U consensus. In addi-
tion, examination of the cases in the existing literature suggests
that CPEs that mediate significant polyadenylation tend to be
close to the polyadenylation signal, from downstream to over-
lapping and up to approximately 60 nt upstream [21,25–29].
The CPE binds cytoplasmic polyadenylation element bind-
ing protein (CPEB), an RNA binding protein containing two
RNA recognition motifs and a zinc finger region, all of which
are required for recognition of the CPE [21,30,31]. In addition
to the fact that many mRNAs bearing a CPE undergo cytoplas-
mic polyadenylation, a wealth of evidence indicates that CPEB is
required for cytoplasmic polyadenylation. Depletion of CPEB
from an egg extract abolishes polyadenylation and injection of
a CPEB antibody blocks it in oocytes and embryos [20,21,
31,32]. N-terminal deletions and phosphorylation site mutants
of CPEB act as dominant negative blockers of cytoplasmic
polyadenylation [20,21,31,32]. In mice, knock out or knock
down of Cpeb1 causes poly(A) tail changes in target mRNAs in
early oogenesis and oocyte maturation [33,34]. CPEB is
therefore the only well-established mRNA specificity factor
for cytoplasmic polyadenylation in vertebrates.
In addition to an mRNA specific element, the nuclear poly(A)
signal (AAUAAA or AUUAAA) is absolutely required for cy-
toplasmic polyadenylation [5,6,11,22,28]. The poly(A) signal is
thought to recruit a variant of the cleavage and polyadenylation
specificity factor (CPSF), a four subunit complex that binds thiselement and mediates polyadenylation in the nucleus [35,36].
The 160 kDa subunit is the RNA binding protein that recognises
the poly(A) signal [37], while the 73 kDa subunit is the endo-
nuclease that mediates the formation of the 3′ ends of all mRNAs
[38–41]. The 100 kDa subunit resembles the 73 kDa subunit but
does not appear to have nuclease activity and its precise function
in 3′ end processing is unknown. The 30 kDa subunit is a zinc
finger protein that has been reported to have some affinity for
RNA and it potentially has endonuclease activity. It was recently
shown to mediate interactions between CPSF and the body of
RNA polymerase II [42–45]. An additional CPSF associated
factor, Fip1, has been shown to mediate the interaction with poly
(A) polymerase and have U-rich RNA binding activity [46]. It
has probably been present in most of the previously utilised
preparations of CPSF and is thought of as a fifth subunit bymany
in the field [40,46].
The 100 and 30 kDa CPSF subunits are present in the Xe-
nopus oocyte cytoplasm, and the 160 kDa subunit has been
inferred to be present from its binding activity, while the 73 kDa
endonuclease is absent from the cytoplasmic CPSF complex
[47]. It is unknown whether Fip1 is present in the oocyte cyto-
plasm. Immunodepletion of the 100 kDa subunit from egg
extracts or expression of a viral protein that blocks nuclear
polyadenylation by binding to the 30 kDa subunit also abolishes
cytoplasmic polyadenylation, demonstrating that CPSF is re-
quired for this process [47]. In addition, CPEB is coimmuno-
precipitated with the 100 kDa CPSF subunit from oocyte
extracts (but not with the 73 kDa subunit) and it binds to the
160 kDa subunit in reticulocyte lysate [47,48]. Whether these
interactions are direct or mediated by other proteins present in
both oocyte extract and reticulocyte lysate is not yet clear.
Curiously, the binding of CPSF to the poly(A) signal is stimu-
lated by a CPE even in the absence of CPEB, a phenomenon that
could be mediated by the RNA binding activity of the 30 kDa
subunit or by Fip1 [46,49]. However, CPEB strongly stimulates
polyadenylation of a CPE containing RNA in a pure reaction
system containing nuclear CPSF and poly(A) polymerase [48]. It
is therefore likely that CPEB improves the recruitment of CPSF
to the mRNA by binding directly to both.
3. Symplekin
Symplekin is a protein found in nuclear complexes containing
CPSF and other processing factors and is thought of as a scaffold
protein involved in 3′ end RNA processing [50–52]. In yeast and
plants, homologues of symplekin are required for proper cleavage
and polyadenylation, and this is possibly also the case in ver-
tebrates [53–55]. In vertebrate somatic cells symplekin is pre-
dominantly nuclear and in epithelial cells also localised at tight
junctions [50,56]. In the Xenopus oocyte, however, symplekin is
also found in the cytoplasm in complexes with the 100 kDa
subunit of CPSF [50]. A symplekin antibody also precipitates
CPEB from oocyte extracts, indicating that the protein is in
cytoplasmic polyadenylation complexes [57]. Moreover, the
symplekin antibody inhibits cytoplasmic polyadenylation in oo-
cytes and extracts [57]. These data strongly suggest that sym-
plekin is involved in cytoplasmic polyadenylation.
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Initially, a form of one of the classical nuclear poly(A)
polymerases was thought to be responsible for cytoplasmic
polyadenylation too. In vitro reconstitution experiments indi-
cated that the poly(A) polymerase (PAP) isolated from bovine
thymus can mediate CPE and poly(A) signal dependent poly-
adenylation [47–49]. Cytoplasmic poly(A) polymerase species
were detected in Xenopus oocytes and an isoform was cloned
that was 87% identical to bovine PAP but lacked the nuclear
localisation signal [58,59]. Three different polyclonal anti-
bodies against this protein inhibited polyadenylation in egg
extracts [58]. However, after these findings the work on the
cytoplasmic poly(A) polymerase stagnated. No native complex
containing CPEB and a PAP isoform was ever reported and
studies on the regulation of PAP activity indicated that the en-
zyme is inactivated by phosphorylation during oocyte matu-
ration, when cytoplasmic polyadenylation is actually induced
[60].
In 2002, a Caenorhabditis elegans germline determinant
called gld-2 was cloned and shown to encode a cytoplasmic
poly(A) polymerase that is recruited to certain mRNAs by an
RNA binding protein [61]. The Gld-2 protein belongs to the
same large family of DNA polymerase β nucleotidyl transfer-
ases, but only has limited additional homology to the classical
poly(A) polymerases and it lacks the RNA binding domain. It
soon transpired that this protein is widely conserved, having
homologues in fission yeast and mammalians [62,63].
The Xenopus Gld-2 protein (xGld-2) coimmunoprecipitated
very efficiently with symplekin in both mature and immature
oocytes. In addition, tagged xGld-2 was shown to bind the
160 kDa CPSF subunit as well as CPEB synthesised in reti-
culocyte lysate [57]. This indicates that xGld-2 can form com-
plexes with symplekin, CPSF and CPEB, although the direct
interactions are as yet unclear. Gld-2 overexpressing oocytes
and extracts supplemented with Gld-2 displayed an increase in
their CPE-dependent polyadenylation and symplekin depleted
extracts regained some polyadenylation activity if they were
replenished with recombinant CPEB, symplekin and Gld-2
[57].
The less than optimal reconstitution of cytoplasmic poly-
adenylation by Gld-2 may indicate that cytoplasmic PAP or an
unknown additional cytoplasmic polyadenylation factor is being
depleted with symplekin. However, it is also very plausible that
not all the supplemented proteins are completely active. Es-
pecially CPEB is notoriously difficult to obtain in a soluble form
and isolation procedures usually include a denaturing step [30].
On the whole, the evidence seems to indicate that xGld-2 is an
authentic cytoplasmic poly(A) polymerase in Xenopus oocytes,
but involvement of the cytoplasmic PAP can as yet not be ex-
cluded. In Drosophila, PAP has been implicated in cytoplasmic
polyadenylation in embryos [64], and although initial experi-
ments implicatedmouseGld-2 in cytoplasmic polyadenylation in
oocytes, polyadenylation appeared unimpaired in a knock out
mouse [65,66]. The cytoplasmic polyadenylation mechanisms in
mammalian germ cells are discussed in more detail by T. Baba
elsewhere in this volume.What part of the cytoplasmic polyadenylation complex
recruits either PAP or Gld-2 is also still an open question. It is
possible that CPEB replaces Fip1 in cytoplasmic polyadenyla-
tion, or that another specific recruitment factor exists for Gld-2.
Also, the nuclear cleavage stimulation factor CstF77 has been
reported to be present in the cytoplasmic polyadenylation com-
plex in Xenopus oocytes, but appears to have an as yet unde-
fined role in translational repression, rather than in cytoplasmic
polyadenylation [67].
In nuclear polyadenylation, binding of the nuclear poly(A)
binding protein, PABP2, is required to limit the length of the
poly(A) tail. It has been suggested that such a function is
required in cytoplasmic polyadenylation, as symplekin immu-
noprecipitates from polyadenylating egg extracts add abnor-
mally long poly(A) tails [57]. It is unknown if the length of the
poly(A) tail added is controlled in cytoplasmic polyadenylation,
but it is worth noting in this context that the main poly(A)
binding protein in oocytes is not the somatic cytoplasmic PABP,
but an embryo specific protein, ePABP, which may have a spe-
cific function in this context [68,69].
Recently, it was shown that ePAB and somatic PABP both can
bind to CPEB, and that this interaction is reduced by phospho-
rylation of CPEB during oocytematuration [65,70]. The ePABP–
CPEB interaction has been proposed to stimulate cytoplasmic
polyadenylation and translational activation, as demonstrated by
depletion experiments [65]. ePABP may therefore be a cyto-
plasmic polyadenylation factor. However, the data presented
appear to show that symplekin is partially depleted with ePABP,
which could explain the reduction in polyadenylation. The add-
back experiment does unfortunately only show a minimal
restoration of polyadenylation. Depletion of CPEB with ePABP
is described for experiments described in the discussion section
of this paper, adding to these concerns. In addition, because
most panels in this paper do not show direct comparisons
between CPE containing and CPE lacking RNA substrates, the
intriguing effects of ePABP depletion could perhaps also be
explained by a general effect of enhanced deadenylation and
reduced translation of all polyadenylated mRNAs, which are
predicted effects of low ePABP levels [68,69]. For the moment,
it therefore appears prudent to reserve judgement on the func-
tion of the CPEB–ePABP interaction.
5. The activation of cytoplasmic polyadenylation
In Xenopus oocytes, meiotic maturation is induced by ste-
roid hormones, probably through the action of both classical
nuclear steroid receptors and a G protein coupled transmem-
brane receptor [71–73]. A rapid drop in cyclic AMP leads to the
inactivation of protein kinase A, which is necessary for the
induction of cytoplasmic polyadenylation. In recent years, prog-
ress has been made in various aspects of the activation mecha-
nisms of cytoplasmic polyadenylation, although the picture is far
from complete.
Tethering of mammalian Gld-2 to an mRNA using a fusion
with an RNA binding domain and an mRNAwith a binding site
causes strong polyadenylation in immature Xenopus oocytes,
indicating that the protein is constitutively active and only needs
220 H.E. Radford et al. / Biochimica et Biophysica Acta 1779 (2008) 217–229to be recruited to the mRNA to elongate the poly(A) tail [62].
However, as described above, Gld-2 is already associated with
the polyadenylation factors in immature oocytes [57]. In addi-
tion, Gld-2 overexpression also leads to robust polyadenylation
of CPE containing RNA in immature oocytes, which implies
that the protein is probably inactivated by factors that are titrated
by the overexpressed protein [57]. Since the action of Gld-2
requires recruitment to the RNA for activity, the titrated factor is
unlikely to be CPEB itself. An intriguing possibility is that the
protein depleted by Gld-2 is the cytoplasmic isoform of poly(A)
ribonuclease (PARN). A 64 kDa catalytically active fragment of
PARN has been found to coimmunoprecipitate with symplekin,
CPEB and Gld-2 in immature but not in mature oocytes and
binds to CPEB and Gld-2 synthesised in reticulocyte lysate
[74]. The full length PARN is not abundantly found in this
complex. The 64 kDa PARN isoform is thought to be re-
sponsible for the short poly(A) tails of CPE containing mRNAs,
as a PARN antibody inhibited CPE-mediated deadenylation in
immature oocytes [74]. In addition, catalytically inactive PARN
can induce polyadenylation of CPE containing RNAs in imma-
ture oocytes and overexpression of wild type PARN represses
the polyadenylation induced by Gld-2 overexpression [74].
These data indicate that PARN is the repressive factor depleted
by Gld-2 injection and that it is the ejection of PARN from the
polyadenylation complex that induces cytoplasmic polyadeny-
lation [74]. There are two possibilities to explain the action of
PARN on CPE containing mRNAs, either Gld-2 continuously
adenylates while PARN takes these nucleotides off, or the
presence of PARN blocks Gld-2 activity, for instance by pre-
venting access to the 3′ end of the mRNA.
Since not all mRNAs are activated by cytoplasmic poly-
adenylation at the same time, the activation of the complexes
must depend at least in part on mRNA specificity factors. In
maturing Xenopus oocytes, cytoplasmic polyadenylation has
been classed into 2 types, early (class I) and late (class II). Early
polyadenylating mRNAs gain a poly(A) tail well before the
activation of cdk1/cyclin B and the breakdown of the nuclear
envelope (germinal vesicle breakdown, GVBD). Early poly-
adenylation is independent of the synthesis of the kinase c-Mos
(which is itself encoded by a class I mRNA), while late poly-
adenylating mRNAs are dependent on c-Mos synthesis and the
subsequent cdk1/cyclin B activation and gain their tails after
GVBD [16,75,76]. The less well characterised polyadenylation
response element (PRE, see above) and its binding factor Mu-
sashi have been shown to be responsible for some of the early
polyadenylation events, despite the fact that these mRNAs also
contain CPEs [15,17]. However, there is a clear correlation
between the placement of the CPEs in an mRNA and the timing
of its polyadenylation [15,77,78]. In addition, some late poly-
adenylating mRNAs also contain PREs/Musashi binding sites
and the histone B4 mRNA, which contains both a PRE and a
CPE, has been reported to be polyadenylated early, but has been
shown to be Mos-dependent, indicating that the current classi-
fication in early and late perhaps oversimplifies the situation
[15,17,75,78].
The evidence for which factor mediates early polyadenyla-
tion rests primarily on the use of dominant negative Musashiand CPEB mutants, which block translation and polyadenyla-
tion of c-Mos mRNA and GVBD [15,17,48]. Charlesworth
et al. compared Musashi and CPEB mutants, and came to the
conclusion that Musashi alone mediates the early polyadenyla-
tion, in contrast to earlier findings by Mendez et al., which
implicated CPEB in the early polyadenylation [17,32]. The
CPEB phosphorylation mutant used by Charlesworth et al. is a
rather weak dominant negative (L.E. Hake, Boston, USA, un-
published observation), so it is possible that CPEB-dependent
early polyadenylation is not completely repressed by it in all
cases. Differences in expression levels and examination of
endogenous or injected RNAs could also explain the discre-
pancies between the two studies. In addition, either or both
dominant negative proteins could be titrating other cytoplasmic
polyadenylation factors and inhibit polyadenylation on mRNAs
to which they do not normally control, or they could fail to enter
a specific mRNA–protein complex due to low exchange rates.
Importantly, injection of a CPEB antibody prevented GVBD and
gave strong repression of polyadenylation of injected early
RNAs, including aMos 3′UTR construct, indicating that CPEB-
mediated early polyadenylation exists [21]. In addition, inter-
ference with pathways that are known to affect CPEB phos-
phorylation and activation leads to a reduction in pre-GVBD
c-Mos mRNA polyadenylation and a delay or block in oocyte
maturation, including in those papers that claim that early
polyadenylation is CPEB-independent [15,16,32,79,80]. How-
ever, there remains the possibility that the same signal trans-
duction pathways ultimately activate Musashi and CPEB, which
would make it impossible to distinguish between the effects of
the two proteins in these experiments, with the possible
exception of the CPEB antibody injection. With the limitations
of the currently available evidence, it seems safest to assume that
Musashi and CPEB both contribute to the polyadenylation of
early mRNAs and that some mRNAs may be exclusively depen-
dent on one or the other. Further work is required to resolve this
issue definitively.
The induction of Xenopus oocyte maturation and early
cytoplasmic polyadenylation by progesterone is dependent on a
drop in cAMP levels and the resulting inhibition of protein
kinase A [17,81]. Downstream of this event is the phosphoryla-
tion of CPEB on Ser174, which happens early in oogenesis.
Although CPEB, CPSF and Gld-2 are already in a complex in
immature oocytes, this phosphorylation appears to induce a
stronger association of CPEB with CPSF and Gld-2 [32,48,82].
Importantly, Ser174 phosphorylation also induces the ejection
of PARN from the polyadenylation complex [74]. Mutation of
Ser174 to alanine results in a dominant negative protein that
inhibits oocyte maturation and early polyadenylation partially
or fully and late polyadenylation completely [15,32,83]. In
addition, injection of a peptide containing the phosphorylation
site delays GVBD considerably, suggesting that it is inhibiting
an early polyadenylation event [32]. All evidence therefore
indicates that phosphorylation of Ser174 is a crucial event in the
activation of cytoplasmic polyadenylation.
There is some controversy surrounding the kinase mediating
the early phosphorylation of CPEB on Ser174. Initially, it was
demonstrated that Aurora A kinase (Eg2) can phosphorylate this
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the phosphorylation site itself [32]. This suggested that the N-
terminally deleted CPEB may owe its dominant negative
properties to the lack of a binding site for Aurora A. In addition,
in vitro polyadenylation reactions containing recombinant
CPEB, purified CPSF and nuclear PAP are strongly stimulated
by the addition of Aurora A [48]. Glycogen synthase kinase 3
(GSK3) is thought to negatively regulate Aurora A by
phosphorylation and this block appears to be relieved during
oocyte maturation [83]. Consistent with a role in early oocyte
maturation, GSK3 overexpression inhibited GVBD in Xenopus
oocytes [83]. However, studies from three independent groups
have failed to detect Aurora A activation early in oocyte
maturation [79,84–86]. In addition, Aurora A inhibitors do not
affect oocyte maturation or CPEB phosphorylation and
depletion of Aurora A from oocyte extracts does not inhibit
early CPEB phosphorylation either [79]. There is therefore
sufficient evidence to throw serious doubt on the role of Aurora
A in the activation of CPE-mediated cytoplasmic polyadenyla-
tion early in oogenesis. In mouse neurons, calmodulin
dependent kinase II (CamKII) can phosphorylate the corre-
sponding site on mouse CPEB, Thr171 [87]. CamKII plays a
role in the induction of mouse oocyte maturation and is known
to be present in Xenopus eggs, and could therefore be an
alternative candidate kinase for mediating the early phosphor-
ylation [88–91]. Because CamKII can be activated indepen-
dently of calcium, the absence of a calcium flux in early oocyte
maturation is not necessarily an obstacle for this hypothesis
[92]. Evidence for a requirement of CamKII activity early in
oocyte maturation would be necessary to make this more than
speculation. However, Aurora A is very active later in oogenesis
and it is undeniably capable of activating CPEB. It therefore
appears likely that at the very least the maintenance of CPEB
phosphorylation on Ser174 is carried out by this kinase.
Mitogen activated protein kinase (MAP kinase) has been
implicated in the activation of early CPE-mediated, but not
PRE-mediated, cytoplasmic polyadenylation [16,17,79,93]. An
early, c-Mos independent activation of MAP kinase has been
detected during oocyte maturation and CPEB is phosphorylated
by MAP kinase on multiple sites [32,79,94]. MAP kinase does
not phosphorylate Ser174, but has been suggested to either
prime CPEB for Ser174 phosphorylation or to activate the
Ser174 kinase [79]. As the early MAPK activation is dependent
on protein synthesis, translational activation of another mRNA
is probably required [94]. One potential candidate is RINGO/
Speedy, a Cdk1 interacting and activating protein that is
transiently expressed after progesterone treatment and required
for oocyte maturation and CPEB phosphorylation [65,95–98].
A guanine nucleotide exchange factor for the Rho family of
GTPases was found to interact with the N-terminal half of
CPEB in a yeast 2 hybrid screen and called XGef [80]. This
interaction was confirmed in oocytes and has been shown to be
direct [80,99]. There appear to be 2 binding sites for CPEB on
XGef [99]. Antibodies against XGef block oocyte maturation
and prevent the polyadenylation and translation of c-Mos
mRNA [80,99]. Conversely, overexpression of XGef acceler-
ates oocyte maturation and c-Mos polyadenylation, independentof the production of c-Mos protein, indicating that it is upstream
of this kinase in the signal cascade of meiotic maturation [80].
XGef enhances the early phosphorylation of CPEB and the DH
domain associated with nucleotide exchange activity is required
for its effects of on cytoplasmic polyadenylation [80,99]. In
addition, a mutant of XGef that retains nucleotide exchange
activity but has impaired binding to CPEB reduced early CPEB
phosphorylation and delayed oocyte maturation [99]. However,
a broad spectrum Rho GTPase inhibitor did not affect oocyte
maturation or CPEB phosphorylation, indicating that the DH
domain may not function to activate a Rho family GTPase, but
is required in another capacity [79]. Strikingly, XGef immuno-
precipitates were found to contain MAPK in both immature and
mature oocytes and it therefore may be required to bring CPEB
to the signalling complexes involved in its phosphorylation
[79].
In another yeast 2 hybrid study, mouse CPEB was found to
bind the small intracellular domain (ICD) of the transmembrane
protein amyloid precursor like protein 1 (APLP1) and its
relatives [100]. In Xenopus oocytes, Gld-2, the CPSF 100 kDa
subunit and symplekin were predominantly associated with the
plasma membrane in the same fractions as overexpressed
APLP1 and immunoprecipitation of CPEB from these fractions
indicates that it can associate with APLP1 [100]. Immunogold
electron microscopy confirmed that CPEB and CPE containing
RNA is associated with membranes. Overexpression of full
length APLP1 induced some cytoplasmic polyadenylation in
untreated oocytes and enhanced the effect of low concentrations
of progesterone. The ICD alone had even stronger effects,
indicating that the action of APLP1 is not dependent on
membrane localisation. After treatment with low concentrations
of progesterone, APLP1 stimulated CPEB phosphorylation on
Ser174 [100]. While the association with amyloid precursor
proteins may have great significance for the role of CPEB and
cytoplasmic polyadenylation in neurons, it is as yet unclear
whether APLP1 or its relatives are required for cytoplasmic
polyadenylation in oocytes and whether it mediates the
membrane association of the cytoplasmic polyadenylation
complexes.
Late cytoplasmic polyadenylation is required for progression
from meiosis I to meiosis II during oocyte maturation [101].
mRNAs that undergo late polyadenylation often have a CPE
overlapping with their poly(A) signal, e.g. UUUUAAUAAA
[15,77,78]. The late polyadenylation during oocyte maturation
is dependent on the activation of the mitotic kinase cdk1 and its
regulatory cyclin subunits [16,77,78,93]. Cdk1 does phosphor-
ylate CPEB leading to degradation of most of the oocyte CPEB
via ubiquitin-mediated degradation [101–103]. This degrada-
tion is required for late polyadenylation to occur. Remarkably,
symplekin bound CPEB appears to represent the stable fraction
of CPEB, as symplekin immunoprecipitates do not show a
difference in CPEB content between immature and mature
oocytes [57]. This implicates that CPEB in polyadenylation
complexes is stable during oocyte maturation, consistent with
the polyadenylation activity observed. A model for late
cytoplasmic polyadenylation can be devised in which the
abundant ‘free’ CPEB (i.e. CPEB in a different complex than
Fig. 1. The activation of CPE-mediated cytoplasmic polyadenylation. In immature oocytes, CPE containing mRNAs already contain all the proteins necessary for
polyadenylation as well as the deadenylase PARN. During oocyte maturation, phosphorylation of CPEB causes a rearrangement of the complex that leads to the
ejection of PARN and the activation of the poly(A) polymerase Gld-2. 4E: eIF4E, 4A: eIF4A. For further description of this process, see the text.
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overlapping the poly(A) signal in late polyadenylating mRNAs
and prevents the recruitment of CPSF and symplekin by the
polyadenylation signal early in oocyte maturation. After cdk1
activation, most free CPEB is depleted and a complex
containing CPEB, symplekin and CPSF binds both the CPE
and the poly(A) signal [101].
A current view of CPE-mediated cytoplasmic polyadenyla-
tion in oocyte maturation is depicted in Figs. 1 and 2 and can be
summarised as follows:
1. The activation of CPE-mediated cytoplasmic polyadenyla-
tion during progesterone induced oocyte maturation is
induced by a drop in protein kinase A activity and requires
an early translation event, perhaps translation of RINGO/
Speedy.
2. This induces the early activation of MAP kinase, which is
associated with the polyadenylation complex through XGef
and phosphorylates CPEB on multiple sites, but not on
Ser174.
3. CPEB is phosphorylated on Ser174 by an as yet not fully
confirmed kinase, possibly Aurora A or CamKII, which is
required for the induction of CPE-mediated polyadenylation
and causes an increase in the binding between Gld-2, CPSF
and CPEB, causing the ejection of PARN from the complex
and allowing Gld-2 to elongate the poly(A) tail of the
mRNA.
4. After GVBD, CPEB is phosphorylated by cdk1 and the free
CPEB is mostly degraded, allowing the CPEB in poly-
adenylation complexes (now probably phosphorylated on
Ser174 by Aurora A) to activate cytoplasmic polyadenyla-
tion on mRNAs which contain a CPE overlapping with the
poly(A) signal.
A surprising number of proteins involved in the activation of
polyadenylation are themselves upregulated by this process.This should create positive feedback loops which amplify the
signal and contribute to the progression of meiotic maturation.
As discussed above, the mRNA for the serine/threonine kinase
c-Mos is one of the early targets of cytoplasmic polyadenylation
[16,75,76]. It is an activator of the MAPK kinase MEK, and its
synthesis leads to further activation of MAP kinase, activation
of cdk1 and phosphorylation of CPEB [71]. The mitotic cyclins,
activators of cdk1, are induced by cytoplasmic polyadenylation,
as is Aurora A [19,26]. Similarly, CamKII is regulated by
cytoplasmic polyadenylation in neurons [104]. Finally, Gld-2
targets its own mRNA, which contains CPEs in its 3′ UTR
[105]. A system with so much positive feedback will require
strong brakes, and it appears that at least in some cases this is
provided by deadenylation factors, as discussed below.
6. Deadenylation and translational repression
The maternal mRNAs that are stored in the oocyte in an
untranslated state have short poly(A) tails, but have been re-
ported to have normal poly(A) tail addition in the nucleus in
both mouse and frog [74,106]. In both organisms, the de-
adenylation of RNA injected into the cytoplasm requires CPEs,
indicating that the CPEB–PARN complex, discussed above,
mediates this process [74,106]. However, RNA substrates con-
taining CPEs alone have not been tested in these experiments
and it is therefore not clear if a CPE is sufficient for de-
adenylation or if other sequence elements are required. In fact
almost all CPE containing mRNAs have putative binding sites
for other deadenylation factors.
Firstly, the deadenylation factor Pumilio binds directly to
CPEB, and therefore could contribute to the deadenylation of
all CPE containing mRNAs [107,108]. Many CPE containing
mRNAs also contain Pumilio binding sites, including cyclin B1
and Gld-2 [97,107–109], indicating that the recruitment of Pu-
milio maybe both by protein–protein and RNA–protein asso-
ciations. Pumilio is a member of a highly conserved family of
Fig. 2. The signal transduction cascade leading to cytoplasmic polyadenylation during oocyte maturation. Schematic representation of the key signalling events in
oocyte maturation and the role of cytoplasmic polyadenylation in this process. For a detailed description, see the text.
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family can mediate translational repression and mRNA desta-
bilisation in organisms from yeast to vertebrates [110,111]. In
yeast, the Puf family protein Mpt5 interacts with the conserved
deadenylase complex CCR4–Pop2–Not, by binding to Pop2/
Caf1 [112–114]. This association was also confirmed for the
human and worm proteins [113]. In addition, Pumilio is known
to aid the recruitment of the translational repressor Nanos, both
in fly and frog [107,115]. Nanos can recruit the CCR4–Pop2–
Not complex by binding to Not4 and contributes to the trans-
lational repression of fly cyclin B [116]. So far, the role of the
CCR4–Pop2–Not complex in poly(A) tail metabolism has not
been studied in Xenopus oocytes and embryos, but the con-
servation of both the recruitment proteins and one of the target
mRNAs (cyclin B) seems to indicate that it is very likely to play a
role.
A subset of mRNAs that are activated by CPE-mediated
cytoplasmic polyadenylation during oocyte maturation loose
their poly(A) tails after fertilisation [19,117,118]. In most cases,
this is mediated by an embryonic deadenylation element (EDEN)
in the 3′ UTR of the mRNA, which binds the deadenylation
factor EDEN-BP [119]. Aurora A, cyclin B1 and c-Mos encod-
ing mRNAs all bind EDEN-BP and the 3′UTR of Gld-2 mRNA
contains good consensus binding sites, making EDEN-BP a
good candidate repressor of the cytoplasmic polyadenylation-mediated positive feedback loops during early embryogene-
sis [105,119–121]. The mammalian ortholog of EDEN-BP,
CUGBP1, can recruit PARN [122]. A similar association of
EDEN-BP and PARN in the Xenopus embryo could explain its
role in deadenylation, but so far this complex has not been
reported. It can therefore not be excluded that EDEN-BP me-
diates its deadenylation activity in Xenopus embryos through
another deadenylase, for instance the CCR4–Pop2–Not com-
plex. No direct contacts between CPEB containing and EDEN
containing complexes has been described so far. Because CPEs,
EDEN sequences,Musashi and Pumilio binding sites often occur
in the same 3′ UTR, their associated complexes can be expected
to compete for the end of the mRNA to mediate deadenylation or
polyadenylation.
Although a short poly(A) tail will lead to inefficient trans-
lation of an mRNA, it is not sufficient for complete translational
repression, as illustrated by the partial polysomal association
of histone B4 mRNA and the accumulation of B4 protein in
Xenopus oocytes [78,123,124]. Many of the other stored ma-
ternal mRNAs have to be strongly translationally repressed to
enable the subsequent stages of growth, maturation and ferti-
lisation of the oocyte [71]. CPEs, Musashi and Pumilio binding
sites can repress translation of specific mRNAs, often in the
absence of a poly(A) tail or in the absence of deadenylation,
indicating that they have an additional function in blocking
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els exist to explain the translational repression by CPEs, some
of which are presented in Fig. 3.
In full grown oocytes, a CPEB binding factor called maskin
was found to associate with the cap binding initiation factor
eIF4E in a manner that should preclude recruitment of eIF4G
and thus inhibit translation [128]. Maskin is a homologue of the
transforming acidic coiled-coil domain protein 3 (TACC3) and
these proteins play a vital role in the formation of the mitotic
spindle in multiple organisms [129–134]. The binding between
maskin and eIF4E is weak but detectable and this association is
abrogated by binding of PABP to the poly(A) tail elongation
and by phosphorylation of maskin in both oocytes and embryos
[129,135–137]. As the eIF4E binding site in maskin appears not
to be present in other organisms, it is not clear how widespread
this regulation is [138]. A more conserved CPEB associated
eIF4E binding protein is the neuronal protein neuroguidin,
which has been proposed to function in a similar manner to
maskin in repressing translation in the nervous system [139].
The deadenylase PARN is a well characterised cap binding
protein and a 5′ cap structure is required for deadenylation by
PARN [140–142]. CPEB can recruit PARN to the mRNA, but
deadenylation still requires a cap structure [74]. This leads to a
conflict between the maskin model and the opposing polymer-
ase-deadenylase model [74,128]. Either the maskin model is true
and eIF4E/maskin is stably bound to the cap and PARN is not
continuously active, or the opposing polymerase-deadenylase
model is correct and CPEB bound PARN is stably bound to the
cap and continuously active, excluding eIF4E from the cap. InFig. 3. Four models of translation repression by CPEs. Schematic representation of
mRNAs. For a detailed description, see the text.fact, PARN could very well mediate both the deadenylation and
the translational repression of mRNAs to which it is recruited by
excluding eIF4E from the mRNA [120].
Both maskin and PARN are absent in early oocytes, so other
repression mechanisms must exist to mediate translational re-
pression in these cells. Recently, a large CPEB containing RNP
complex was found in early oocytes [143]. This complex con-
tains several proteins found in P-bodies and related RNP
granules that have been implicated in both translational control
and mRNA degradation [144]. In mammalian cells, CPEB can
also be found in large RNP granules including P-bodies [145].
The early oocyte CPEB complex contains the eIF4E variant
eIF4E1b, the eIF4E binding protein 4E-T, the RNA helicase
Xp54 (Ddx6, Rck, Me31B, Dhh1) and the P-body components
p100 (Pat1) and Rap55 (Scd6, CAR-1). It does not contain
PARN, maskin or the canonical cap binding initiation factor
eIF4E1a. Rap55 and Xp54 can mediate translational repression
in Xenopus oocytes when tethered to an mRNA [146–148]. In
addition, the yeast homologues of both proteins, as well as of
p100, are involved in general repression of translation [149].
Strikingly, the yeast Pumilio homologue Mpt5 recruits Dhh1, a
homologue of the Xp54 RNA helicase, indicating that Pumilio-
mediated translational repression may involve a similar com-
plex [113]. The mechanism of this highly conserved type of
translational repression is not entirely clear, but it is likely to
involve assembly of large RNP particles that exclude translation
initiation factors and/or ribosomes. In addition, eIF4E1b was
shown to be defective in eIF4G binding and to bind 4E-T
independently of the canonical eIF4E binding site. This impliessome of the proposed translational repression mechanisms for CPE containing
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through sequestration of the cap by eIF4E1b, which would
exclude eIF4E1a/eIF4G from the mRNA. Indeed, tethering of
4E-T causes translational repression and injection of an eIF41b
antibody enhances oocyte maturation [143]. It is as yet unclear
which proteins in the early complex bind directly to CPEB and
therefore are likely to confer specific repression of CPE con-
taining mRNAs. As eIF4E1b is also the predominant CPEB
associated eIF4E in fully grown oocytes, this protein could in
principle convey CPE-mediated translational repression through-
out oogenesis [67,143].
At present it is difficult to choose amongst the multitude of
models for translational repression by CPEs. Some of the com-
plexes detected by pulldown and immunoprecipitation may not
contain the majority of the repressed mRNA, even though pre-
sence of some mRNA was demonstrated by RT-PCR. Alterna-
tively, it maywell be that every one of these models is correct at a
particular stage of oogenesis or embryogenesis or that the re-
pression is different for specific mRNAs, depending on binding
sites for other proteins such as Pumilio and EDEN-BP. An
attractive option is that sequestration to P-body like large
complexes is the result of translational repression and acts as an
enhancer of translational repression, while smaller, more mRNA
specific translational repression complexes are formed during
the movement of mRNAs in and out of P-bodies. To distinguish
between these models, it will be important to characterise the cap
binding proteins and P-body components present on specific
mRNAs at different developmental stages.
7. Cytoplasmic polyadenylation and translational activation
The simplest explanation for why cytoplasmic polyadenyla-
tion leads to translational activation is that the poly(A) tail
recruits translation initiation factors through its association with
PABP and that these mediate release of the mRNA from the
repression complexes, either by exchanging the cap binding
complex for eIF4E1a/eIF4G or by somehow extracting the
mRNA from a P-body-like RNP complex, a function which has
been ascribed to PABP in yeast [150]. In support of this hypo-
thesis, the translational repression of the histone B4 and cyclin
B1 3′ UTRs on mRNAs injected into Xenopus oocytes can be
abolished by the addition of a poly(A) tail, at least until that tail
is deadenylated [29,74]. However other mRNAs (G10, Cl2)
appear to be still repressed even if a long poly(A) tail is added
and only become translated if the mRNA is actively poly-
adenylated in the maturing oocyte [6,13]. In a seminal expe-
riment, Barkoff et al. cleaved the endogenous c-Mos mRNA
with an oligonucleotide, removing the polyadenylation signal
and CPE. As expected, this abrogated c-Mos mRNA polyade-
nylation and translation in oocytes exposed to progesterone. A
‘prosthetic’ poly(A) tail was tethered to the remaining 3′ UTR
using basepairing. This did not lead to c-Mos synthesis in un-
stimulated oocytes, but restored the synthesis of c-Mos in re-
sponse to progesterone [76]. This suggests that, at least for the
translation of c-Mos mRNA, both the presence of a poly(A) tail
and an additional, polyadenylation independent, modification of
the mRNP are required for translational activation.8. Discussion
Since the discovery of CPEB ten years ago, our knowledge of
the mechanisms of CPE-mediated cytoplasmic polyadenylation
has made great strides, especially in Xenopus oocytes. However,
there are still quite a few questions that need to be resolved, for
instance:
1. Amore systematic investigation of the consensus CPE sequence
and its maximum distance to the poly(A) signal would enable a
more reliable bioinformatic prediction of the targets of CPE-
mediated cytoplasmic polyadenylation.Are allmRNAs contain-
ing these sequences polyadenylated during oocyte maturation?
2. The relative roles of Gld-2 and PAP in cytoplasmic poly-
adenylation need to be further evaluated. Can they substitute
for each other? What are their contact points in the cyto-
plasmic polyadenylation complex? A cytoplasmic polyade-
nylation system reconstituted from pure components would
be ideal to resolve these questions.
3. The kinase(s) responsible for the early activating phosphor-
ylation on Ser174 of CPEB should be identified un-
equivocally. If Aurora A is responsible, why do inhibitors
of its activity not block oocyte maturation and can no early
activation of this kinase be detected? Do inhibitors of CamKII
affect early polyadenylation? What is the signal transduction
cascade leading to induction of the activating kinase?
4. What are the relative roles of Musashi and CPEB in the
polyadenylation of c-Mos mRNA and other substrates? How
do dominant negative mutants of CPEB andMusashi achieve
their repressive functions? May there be off target effects
through titration of common polyadenylation factors or sig-
nal transduction machinery?
5. What are the direct interaction between proteins and RNA
elements in the cytoplasmic polyadenylation complex?Much
of the work discussed here has been performed either in
oocyte or reticulocyte lysates, where other interacting pro-
teins may be present. It appears necessary that these inter-
actions are mapped in detail in vitro or in a 2 hybrid system,
as this could lead to predictions for the functions of dominant
negative mutants and potentially clarify how different com-
plexes are assembled.
6. Are the complexes on cytoplasmic polyadenylation sequences
other than the CPE similar to the CPEB associated com-
plexes? For instance, do Gld2 or PAP associate with the RNA
binding proteins that recognise them?
7. Which models for translational repression and deadenylation
of CPE containing mRNAs are correct in what stage of
oogenesis? Again, a more intimate knowledge of the direct
interactions involved in assembling the repression com-
plexes is likely to yield important new investigative tools for
resolving this question. In addition, the study of mRNP
complexes assembled in vivo could yield some more con-
clusive answers.
8. Are the polyadenylation and translation repression complexes
identical for each CPE containing mRNA or are there mRNA
specific differences in the complexes? Immunoprecipitation
followed by RT-PCR and RNA affinity chromatography can
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ods that target specific mRNPs are likely to be crucial to
obtain a full answer.
Some of the controversies discussed here are a result of the
experimental restrictions of the Xenopus oocyte and egg sys-
tems. These systems are very good for biochemical assays both
in injected oocytes and egg extracts and they provide ample
material for purification and identification. However, the high
levels of stable maternal proteins make clean knock down or
knock out experiments impossible in most cases, which has led
to a heavy reliance on dominant negative approaches. To re-
solve some of the outstanding issues we are therefore likely to
have to look to vertebrate genetic systems such as mouse and/or
to develop tissue culture based cytoplasmic polyadenylation
systems that are amenable to siRNA knock down, for instance
using neuronal cells or cells synchronised in the cell cycle.
The advent of high throughput screens will strongly impact
the field of cytoplasmic polyadenylation in the near future as
the results of RNP immunoprecipitation microarray experi-
ments and poly(A) tail profiling studies will increase our
knowledge of the range of mRNA substrates [9,151–153].
Such screens may also identify new cytoplasmic polyadenyla-
tion elements as well as novel cell types and biological
processes in which this form of regulation is involved. Only
one cytoplasmic polyadenylation element and its binding
protein have so far been studied in detail, predominantly in
oocyte maturation. As outlined above, a large number of
important questions are still unresolved, even in this one
system. With at least three other cytoplasmic polyadenylation
sequences in existence in oocytes alone and the evidence that
cytoplasmic polyadenylation also is involved in neuronal
events and the mitotic cell cycle [9], there appears ample
scope for expansion of the field in the near future.
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